atai Life Sciences
also invests · investor profile5 known investors
Find your way into atai Life Sciences
Sign up to see every warm intro you have to atai Life Sciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the atai Life Sciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Atai Beckley develops rapid-acting, durable, and convenient therapies for mental health conditions where patients currently have limited treatment options. The company focuses on evidence-based drug development aimed at improving patient outcomes in mental health care.
Investors · 5
How we know: Daniel Gutenberg's portfolio page · Not right? Tell us
How we know: Nucleus Adventure Capital's portfolio page · Not right? Tell us
How we know: P53 Invest's portfolio page · Not right? Tell us
How we know: Palo Santo VC's portfolio page · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Frequently asked questions
- What does atai Life Sciences do?
- Atai Beckley develops rapid-acting, durable, and convenient therapies for mental health conditions where patients currently have limited treatment options. The company focuses on evidence-based drug development aimed at improving patient outcomes in mental health care.
- Who are atai Life Sciences's investors?
- atai Life Sciences's investors include Daniel Gutenberg, Nucleus Adventure Capital, P53 Invest, Palo Santo VC, PsyMed Ventures.

